# Gilead Sciences (GILD) EPS: $6.78 in 2025

URL: https://funkfolio.com/stock/GILD/eps

> Gilead Sciences (GILD) earnings per share (EPS) was $6.78 in fiscal 2025, up 1684.2% from fiscal 2024. Over five fiscal years it grew 132.4% a year.

---

## Gilead Sciences (GILD) earnings per share (EPS)

**Earnings per share · fiscal 2025:** $6.78 year ended Dec 31, 2025

Gilead Sciences (GILD) reported diluted earnings per share of $6.78 in fiscal 2025 (the year ended December 31, 2025). That is 1684.2% higher than the $0.38 of fiscal 2024. Figures as of 18 Nov 2026, 04:20 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Earnings per share, fiscal 2025:** $6.78
- **Change on fiscal 2024:** +1684.2%
- **Growth, 5 years:** +132.4% a year
- **Growth, 10 years:** −5.5% a year
- **Highest on record:** $11.91 fiscal 2015
- **Lowest on record:** $0.10 fiscal 2020
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 04:20 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Gilead Sciences earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 132.4% a year; over ten years the rate was −5.5% a year. Across the 19 fiscal years on record (2007–2025), the highest was $11.91 in fiscal 2015 and the lowest $0.10 in fiscal 2020.

### Earnings per share by fiscal year

### Gilead Sciences earnings per share (EPS), year by year

Gilead Sciences (GILD) earnings per share (EPS) by fiscal year

| Fiscal year | Earnings per share | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $6.78 | 1,684.2% up | Dec 31, 2025 |
| 2024 | $0.38 | 91.6% down | Dec 31, 2024 |
| 2023 | $4.50 | 23.6% up | Dec 31, 2023 |
| 2022 | $3.64 | 26.2% down | Dec 31, 2022 |
| 2021 | $4.93 | 4,830.0% up | Dec 31, 2021 |
| 2020 | $0.10 | 97.6% down | Dec 31, 2020 |
| 2019 | $4.22 | 1.2% up | Dec 31, 2019 |
| 2018 | $4.17 | 18.8% up | Dec 31, 2018 |
| 2017 | $3.51 | 64.7% down | Dec 31, 2017 |
| 2016 | $9.94 | 16.5% down | Dec 31, 2016 |
| 2015 | $11.91 | 62.0% up | Dec 31, 2015 |
| 2014 | $7.35 | 306.1% up | Dec 31, 2014 |
| 2013 | $1.81 | 10.4% up | Dec 31, 2013 |
| 2012 | $1.64 | 7.3% down | Dec 31, 2012 |
| 2011 | $1.77 | 6.6% up | Dec 31, 2011 |
| 2010 | $1.66 | 17.7% up | Dec 31, 2010 |
| 2009 | $1.41 | 36.9% up | Dec 31, 2009 |
| 2008 | $1.03 | 25.6% up | Dec 31, 2008 |
| 2007 | $0.82 | — | Dec 31, 2007 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

### How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

### Earnings per share at health care companies of similar size

Earnings per share of Gilead Sciences and comparable companies

| Company | Earnings per share | Fiscal year |
| --- | --- | --- |
| Gilead Sciences GILD | $6.78 | 2025 |
| [Novo Nordisk NVO](https://funkfolio.com/stock/NVO/eps) | DKK 23.03 | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Gilead Sciences, figure by figure

- [Gilead Sciences market cap](https://funkfolio.com/stock/GILD/market-cap)
- [Gilead Sciences revenue](https://funkfolio.com/stock/GILD/revenue)
- [Gilead Sciences earnings](https://funkfolio.com/stock/GILD/earnings)
- [Gilead Sciences P/E ratio](https://funkfolio.com/stock/GILD/pe-ratio)
- [Gilead Sciences P/S ratio](https://funkfolio.com/stock/GILD/ps-ratio)
- [Gilead Sciences P/B ratio](https://funkfolio.com/stock/GILD/pb-ratio)
- [Gilead Sciences free cash flow](https://funkfolio.com/stock/GILD/free-cash-flow)
- [Gilead Sciences operating margin](https://funkfolio.com/stock/GILD/operating-margin)
- [Gilead Sciences dividend](https://funkfolio.com/stock/GILD/dividend)
- [Gilead Sciences shares outstanding](https://funkfolio.com/stock/GILD/shares-outstanding)
- [Gilead Sciences total debt](https://funkfolio.com/stock/GILD/total-debt)
- [Gilead Sciences cash on hand](https://funkfolio.com/stock/GILD/cash)
- [Gilead Sciences total assets](https://funkfolio.com/stock/GILD/total-assets)
- [Gilead Sciences return on equity (ROE)](https://funkfolio.com/stock/GILD/roe)
- [Gilead Sciences return on invested capital (ROIC)](https://funkfolio.com/stock/GILD/roic)

[Gilead Sciences (GILD) overview: price, valuation and scorecard](https://funkfolio.com/stock/GILD) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Gilead Sciences earnings per share (EPS): questions and answers

**What is Gilead Sciences's diluted earnings per share?**

Gilead Sciences (GILD) reported diluted earnings per share of $6.78 in fiscal 2025 (the year ended December 31, 2025). That is 1684.2% higher than the $0.38 of fiscal 2024.

**What is the growth rate of Gilead Sciences's diluted earnings per share?**

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 132.4% a year; over ten years the rate was −5.5% a year.

**What are the highest and lowest diluted earnings per share figures on record for Gilead Sciences?**

Across the 19 fiscal years on record (2007–2025), the highest was $11.91 in fiscal 2015 and the lowest $0.10 in fiscal 2020.

**How is Gilead Sciences's diluted earnings per share calculated?**

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

### Learn: earnings per share (EPS)

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Gilead Sciences (GILD) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.
